⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CYTK News
Cytokinetics Inc.
Identifix’s Direct-Hit® Mobile Brings OEM Repair Manuals to the Bay, Transforms How Repairs Get Done
globenewswire.com
CYTK
Form 8-K
sec.gov
CYTK
Cytokinetics Announces Closing of Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $805 Million
globenewswire.com
CYTK
Cytokinetics Announces Pricing of Upsized Public Offering of Common Stock
globenewswire.com
CYTK
Cytokinetics Announces Proposed Public Offering of Common Stock
globenewswire.com
CYTK
Form 8-K
sec.gov
CYTK
Form 8-K
sec.gov
CYTK
Cytokinetics Reports First Quarter 2026 Financial Results and Provides Business Update
globenewswire.com
CYTK
Cytokinetics Announces Positive Topline Results from ACACIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients with Non-Obstructive Hypertrophic Cardiomyopathy
globenewswire.com
CYTK
Cytokinetics to Announce Topline Results from ACACIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients with Non-Obstructive Hypertrophic Cardiomyopathy, on May 5, 2026
globenewswire.com
CYTK